Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001562180-15-000716)

Filing Details

Accession Number:: 0001562180-15-000716
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2015-09-01 15:59:00
Reporting Period:: 2015-08-31

Filing Date:: 2015-09-01
Accepted Time:: 2015-09-01 15:59:00
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1597553	Sage Therapeutics Inc.	SAGE	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1612859	Stephen Kanes	C/O Sage Therapeutics, Inc. 215 First Street Cambridge MA 02142	Chief Medical Officer	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2015-08-31	12,000	$53.12	31,948	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

The sales reported on this Form 4 were effected pursuant to a trading plan adopted pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
This transaction was executed in multiple trades at prices ranging from $53.00 USD to $53.39 USD. The price reported above reflects the weighted average sale price.